How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology

Pedretti, Roberto FE; Hansen, Dominique; Ambrosetti, Marco; Back, Maria; Berger, Thomas; Ferreira, Mariana Cordeiro; Cornelissen, Veronique; Davos, Constantinos H; Doehner, Wolfram; Zarzosa, Carmen de Pablo Y; Frederix, Ines; Greco, Andrea; Kurpas, Donata; Michal, Matthias; Osto, Elena; Pedersen, Susanne; Salvador, Rita Esmeralda; Simonenko, Maria; Steca, Patrizia; Thompson, David R; Wilhelm, Matthias; Abreu, Ana

doi:10.1093/eurjpc/zwac204

How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology

Author:

Pedretti, Roberto FE

Hansen, Dominique ; Ambrosetti, Marco ; Back, Maria ; Berger, Thomas ; Ferreira, Mariana Cordeiro ; Cornelissen, Veronique ; Davos, Constantinos H ; Doehner, Wolfram ; Zarzosa, Carmen de Pablo Y ; Frederix, Ines ; Greco, Andrea ; Kurpas, Donata ; Michal, Matthias ; Osto, Elena ; Pedersen, Susanne ; Salvador, Rita Esmeralda ; Simonenko, Maria ; Steca, Patrizia ; Thompson, David R ; Wilhelm, Matthias ; Abreu, Ana

Keywords:

Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, Cardiovascular disease, Cardiovascular risk, Secondary prevention, Adherence, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, HEART-FAILURE PATIENTS, CARDIAC REHABILITATION, RISK-FACTORS, HEALTH LITERACY, LIFE-STYLE, SCIENTIFIC STATEMENT, SEX-DIFFERENCES, POSITION PAPER, CORONARY, Humans, Cardiovascular Diseases, Secondary Prevention, Cardiology, Patient Compliance, Life Style, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, 3201 Cardiovascular medicine and haematology

Abstract:

A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for CVD risk factors and CVD have been observed consistently over the last few decades. Hence, achieving optimal adherence to lifestyle measures and guideline-directed medical therapy in secondary prevention and rehabilitation is a great challenge to many healthcare professionals. Therefore, in this European Association of Preventive Cardiology clinical consensus document, a modern reappraisal of the adherence to optimal treatment is provided, together with simple, practical, and feasible suggestions to achieve this goal in the clinical setting, focusing on evidence-based concepts.